Year archive

CSPC Pharmaceutical Group Limited — 2024 filings

All 154 regulatory filings released by CSPC Pharmaceutical Group Limited (1093) in 2024, sourced directly from the official regulator.

154 Filings

2024 Period

2024 filings (154)

Filing	Released	Lang
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-30	English
VOLUNTARY ANNOUNCEMENT - LEUPRORELIN EXTENDED-RELEASE INJECTION (SYH9016) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-12-30	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-27	English
VOLUNTARY ANNOUNCEMENT - SYH2062 INJECTION (siRNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-12-23	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-23	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-20	English
VOLUNTARY ANNOUNCEMENT - SYS6005 (ANTIBODY-DRUG CONJUGATE) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-12-20	English
VOLUNTARY ANNOUNCEMENT - SYS6043 (ANTIBODY-DRUG CONJUGATE) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-12-20	English
VOLUNTARY ANNOUNCEMENT - SEMAGLUTIDE LONG-ACTING INJECTION (SYH9017) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-12-20	English
CONNECTED TRANSACTIONS AND CONTINUING CONNECTED TRANSACTION Regulatory Filings	2024-12-19	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-19	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-18	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-17	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-16	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-13	English
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT FOR SYH2039 WITH BEIGENE Regulatory Filings	2024-12-13	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-12-10	English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF APPLICATION FOR MARKETING APPROVAL OF SYHX2011 FOR THE TREATMENT OF ADVANCED BREAST CANCER Regulatory Filings	2024-12-09	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2024-12-06	English
APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTOR Board/Management Information	2024-12-06	English
VOLUNTARY ANNOUNCEMENT - TEDIZOLID PHOSPHATE TABLETS OBTAINS DRUG REGISTRATION APPROVAL Regulatory Filings	2024-12-04	English
VOLUNTARY ANNOUNCEMENT - CRB-701 (SYS6002) GRANTED FAST TRACK DESIGNATION BY THE U.S. FDA Regulatory Filings	2024-12-04	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2024 Share Issue/Capital Change	2024-12-02	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-29	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-28	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-27	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-26	English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF BIOLOGIC LICENSE APPLICATION OF USTEKINUMAB INJECTION Regulatory Filings	2024-11-26	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-25	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-22	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-21	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-20	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-19	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-11-18	English
QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024 Interim / Quarterly Report	2024-11-15	English
VOLUNTARY ANNOUNCEMENT - BIVALENT HPV mRNA THERAPEUTIC VACCINE (SYS6026) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-11-12	English
DATE OF BOARD MEETING Regulatory Filings	2024-11-05	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2024 Share Issue/Capital Change	2024-11-01	English
PROFIT WARNING Regulatory Filings	2024-10-31	English
VOLUNTARY ANNOUNCEMENT - FIRST mRNA-LNP-BASED CAR-T CELL INJECTION (SYS6020) OBTAINS FURTHER CLINICAL TRIAL APPROVAL FOR NEW INDICATION Regulatory Filings	2024-10-25	English
UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024 Interim / Quarterly Report	2024-10-23	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2024-10-15	English
VOLUNTARY ANNOUNCEMENT - OMALIZUMAB FOR INJECTION OBTAINS MARKETING APPROVAL GRANTED BY NMPA Regulatory Filings	2024-10-08	English
VOLUNTARY ANNOUNCEMENT - CPO301 RECEIVES FAST TRACK DESIGNATION FROM THE US FDA Regulatory Filings	2024-10-08	English
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT FOR YS2302018 WITH ASTRAZENECA Capital/Financing Update	2024-10-07	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024 Transaction in Own Shares	2024-10-02	English
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH JIANGSU ALPHAMAB FOR THE DEVELOPMENT AND COMMERCIALIZATION OF JSKN003 IN MAINLAND CHINA Regulatory Filings	2024-09-30	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2024-09-20	English
VOLUNTARY ANNOUNCEMENT - VALSARTAN LEVOAMLODIPINE MALEATE TABLETS OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-09-20	English
VOLUNTARY ANNOUNCEMENT - FURTHER SHARE BUY-BACK PLAN OF UP TO HK$5 BILLION Transaction in Own Shares	2024-09-19	English
NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM Report Publication Announcement	2024-09-19	English
LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM Regulatory Filings	2024-09-19	English
NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM Report Publication Announcement	2024-09-19	English
2024 INTERIM REPORT Interim / Quarterly Report	2024-09-19	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-17	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-16	English
VOLUNTARY ANNOUNCEMENT - AMPHOTERICIN B LIPOSOME FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL Regulatory Filings	2024-09-16	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-13	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-12	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-11	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-10	English
VOLUNTARY ANNOUNCEMENT - APREPITANT INJECTION OBTAINS DRUG REGISTRATION APPROVAL Regulatory Filings	2024-09-09	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-09	English
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF DR. LIU YONGJUN AS EXECUTIVE PRESIDENT AND PRESIDENT OF GLOBAL RESEARCH AND DEVELOPMENT Board/Management Information	2024-09-09	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-05	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-04	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-03	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-09-02	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024 Regulatory Filings	2024-09-02	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-08-30	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-08-29	English
VOLUNTARY ANNOUNCEMENT - DEXRAZOXANE FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL Regulatory Filings	2024-08-28	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-08-28	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-08-27	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-08-26	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-08-23	English
NEXT DAY DISCLOSURE RETURNS Transaction in Own Shares	2024-08-22	English
2024 INTERIM DIVIDEND Notice of Dividend Amount	2024-08-21	English
2024 INTERIM RESULTS Interim / Quarterly Report	2024-08-21	English
UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE SIX MONTHS ENDED 30 JUNE 2024 Interim / Quarterly Report	2024-08-16	English
VOLUNTARY ANNOUNCEMENT - FIRST mRNA-LNP-BASED CAR-T CELL INJECTION (SYS6020)OBTAINS CLINICAL TRIAL APPROVAL FOR NEW INDICATION Regulatory Filings	2024-08-09	English
DATE OF BOARD MEETING Report Publication Announcement	2024-08-09	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2024 Transaction in Own Shares	2024-08-02	English
CONTINUING CONNECTED TRANSACTIONS - PURSUANT TO RULE 14A.60(1) OF THE LISTING RULES Regulatory Filings	2024-07-25	English
VOLUNTARY ANNOUNCEMENT - mRNA RSV VACCINE (SYS6016) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-07-11	English
NEXT DAY DISCLOSURES RETURNS Share Issue/Capital Change	2024-07-11	English
VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE SYS6023 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. Regulatory Filings	2024-07-08	English
VOLUNTARY ANNOUNCEMENT - ROXADUSTAT CAPSULES OBTAIN DRUG REGISTRATION APPROVAL Regulatory Filings	2024-07-05	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2024 Regulatory Filings	2024-07-02	English
VOLUNTARY ANNOUNCEMENT - ENLONSTOBART INJECTION OBTAINS CONDITIONAL MARKETING APPROVAL GRANTED BY NMPA Regulatory Filings	2024-06-28	English
VOLUNTARY ANNOUNCEMENT - PALBOCICLIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL Regulatory Filings	2024-06-28	English
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO MASTER PURCHASE AGREEMENT Regulatory Filings	2024-06-28	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-06-26	English
VOLUNTARY ANNOUNCEMENT - FIRST mRNA-LNP-BASED CAR-T CELL INJECTION (SYS6020) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-06-25	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-06-25	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-06-24	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-06-21	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-06-12	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-06-11	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-06-07	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-06-04	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-06-03	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024 Transaction in Own Shares	2024-06-03	English
VOLUNTARY ANNOUNCEMENT - OLAPARIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL Regulatory Filings	2024-06-03	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-05-31	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-05-30	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2024-05-29	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2024-05-28	English
RETIREMENT OF EXECUTIVE DIRECTORS, APPOINTMENT OF EXECUTIVE DIRECTORS AND CHANGE OF AUTHORISED REPRESENTATIVE Board/Management Information	2024-05-28	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 MAY 2024 Declaration of Voting Results & Voting Rights Announcements	2024-05-28	English
QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2024 Interim / Quarterly Report	2024-05-27	English
VOLUNTARY ANNOUNCEMENT - AMENDMENTS TO THE RULES OF THE RESTRICTED SHARE AWARD SCHEME Capital/Financing Update	2024-05-21	English
VOLUNTARY ANNOUNCEMENT - RECOMBINANT FULLY HUMAN ANTI-Beta Klotho MONOCLONAL ANTIBODY DRUG (JMT202) OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-05-17	English
DATE OF BOARD MEETING Regulatory Filings	2024-05-14	English
VOLUNTARY ANNOUNCEMENT - PERAMIVIR INJECTION OBTAINS DRUG REGISTRATION APPROVAL Regulatory Filings	2024-05-14	English
NEXT DAY DISCLOSURE RETURN Share Issue/Capital Change	2024-05-03	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024 Regulatory Filings	2024-05-02	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-04-26	English
VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. Regulatory Filings	2024-04-26	English
NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM Report Publication Announcement	2024-04-25	English
NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM Report Publication Announcement	2024-04-25	English
LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM Regulatory Filings	2024-04-25	English
PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2024 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF) Proxy Solicitation & Information Statement	2024-04-25	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2024-04-25	English
PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, MANDATE TO GRANT OPTIONS AND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2024-04-25	English
2023 Environmental, Social and Governance Report Regulatory Filings	2024-04-25	English
2023 ANNUAL REPORT Annual Report	2024-04-25	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-04-24	English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2024-04-23	English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2024 Interim / Quarterly Report	2024-04-22	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-04-22	English
GRANT OF SHARE AWARDS PURSUANT TO THE SHARE AWARD SCHEME OF THE COMPANY Capital/Financing Update	2024-04-22	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-04-19	English
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO MASTER SALES AGREEMENT Regulatory Filings	2024-04-19	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-04-18	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-04-17	English
NEXT DAY DISCLOSURES RETURNS Transaction in Own Shares	2024-04-16	English
NEXT DAY DISCLOSURES RETURNS Share Issue/Capital Change	2024-04-15	English
EXERCISE OF SHARE OPTIONS UNDER THE SHARE OPTION SCHEME Share Issue/Capital Change	2024-04-15	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024 Regulatory Filings	2024-04-02	English
VOLUNTARY ANNOUNCEMENT - SEMAGLUTIDE INJECTION FOR OVERWEIGHT/OBESITY INDICATION OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-03-25	English
VOLUNTARY ANNOUNCEMENT - DAPAGLIFLOZIN TABLETS OBTAINS DRUG REGISTRATION APPROVAL Regulatory Filings	2024-03-22	English
VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE SYS6023 OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-03-20	English
CASH DIVIDEND ANNOUNCEMENT FOR EQUITY ISSUER Notice of Dividend Amount	2024-03-20	English
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 Annual Report	2024-03-20	English
VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039)OBTAINS CLINICAL TRIAL APPROVAL Regulatory Filings	2024-03-18	English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2023 Regulatory Filings	2024-03-14	English
DATE OF BOARD MEETING Regulatory Filings	2024-03-08	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024 Regulatory Filings	2024-03-01	English
VOLUNTARY ANNOUNCEMENT - INDICATION FOR ACUTE ISCHEMIC STROKE OF MINGFULE (RECOMBINANT HUMAN TNK TISSUE-TYPE PLASMINOGEN ACTIVATOR FOR INJECTION) OBTAINS MARKETING APPROVAL Regulatory Filings	2024-02-05	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024 Regulatory Filings	2024-02-01	English
KEY FINANCIAL INFORMATION OF A SUBSIDIARY FOR THE YEAR ENDED 31 DECEMBER 2023 Capital/Financing Update	2024-01-24	English
VOLUNTARY ANNOUNCEMENT - BISPECIFIC FUSION PROTEIN DRUG JMT106 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. Regulatory Filings	2024-01-15	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023 Regulatory Filings	2024-01-03	English

Filings by year

2026 51 filings
2025 144 filings
2024 154 filings
2023 106 filings
2022 93 filings
2021 104 filings
2020 79 filings
2019 80 filings
2018 69 filings
2017 54 filings
2016 51 filings
2015 47 filings
2014 55 filings
2013 64 filings
2012 52 filings
2011 34 filings
2010 31 filings
2009 37 filings
2008 29 filings
2007 41 filings
2006 15 filings
2005 26 filings
2004 20 filings
2003 24 filings
2002 12 filings
2001 19 filings
2000 5 filings
1999 14 filings